A B S T R A C T Radiolabeled photobilirubins, prepared in vitro by anaerobic illumination of [14C]bilirubin, were injected intravenously into homozygous jaundiced Gunn rats with an external bile fistula. With the animals kept in darkness, the labeled photobilirubins were excreted rapidly in bile. Photobilirubins IA and IB were excreted primarily as unconjugated bilirubin, whereas photobilirubin II was excreted primarily as photobilirubin II and not converted into bilirubin. Bile of Gunn rats given no exogenous pigments, but undergoing phototherapy, contained a large proportion of photobilirubin II and, ifcollected in liquid nitrogen, traces of photobilirubins I; neither was found in bile when these rats were kept in the dark. Because there is prior evidence that these photobilirubins are isomers of bilirubin, these experiments indicate that the major mechanism of phototherapy is photoisomerization of bilirubin. Photobilirubin II. is the unidentified major photoderivative described previously, whereas formation of photobilirubins IA and IB, and their reversion to bilirubin-IXa, account for the remarkably increased output of the parent pigment during phototherapy.
INTRODUCTION
The formation of oxidative bilirubin derivatives by photosensitized singlet oxygen attack was initially postulated as an important mechanism for increased This work was presented in part at Digestive Disease Week, Toronto, Ontario Canada, May 1977. (Gastroenterology. 72: 1180. [Abstr.1).
11). The properties of these photobilirubins suggested that they were bilirubin isomers, and that they corresponded to the major bilirubin derivatives formed during phototherapy of jaundice in vitro. Possibly related in vitro photoproducts have been reported by Lightner et al. (12) (13) (14) , though direct comparisons are not possible since they were unable to isolate and purify their derivatives (16) . This paper supports the role of the photobilirubins in the catabolism of bilirubin during phototherapy of the Gunn rat by showing that they are excreted rapidly in bile when given intravenously to the Gunn rat, and by showing that they appear endogenously in bile collected during phototherapy of these jaundiced animals. In view of prior in vivo studies (6, 8, 10, 11, (13) (14) (15) (16) , this work suggests also that the major mechanism of increased bilirubin catabolism during phototherapy is probably photoisomerization, rather than photo-oxidation of bilirubin.
METHODS
Normal rat serum was prepared by centrifugation (900 g for 20 min ) of blood drawn by cardiac puncture of 450-600 g male Spraguie-Dawley rats under light ether anesthesia. All chemicals were analytical reagent grade.
Preparation of bile pigments [14C] Bilirtubin was preplared l)iosynthetically fromii [4-`4C] aminolevuliinic acid (New Englaind Ntuclear, Boston, Mass.) administered intravenously to Sprague-Dawlev rats (300-350 g) with a bile fisttula. The labeled bilirlibin was isolated from bile, crystallized, and its specific activity dletermllinedl as descriled by Ostrow et al. (17) . Specific activities raniged from 1,600 to 5,550 dpm4i/Ag. The term "biliruhin," as used in this paper, refers to the natuiral IXa isomiier in the 4Z, 15Z configuration (18) .
Irradiated biliruibini. l[4C]Bilirubin (500 gg), dissolved in 5 ml chloroformii containiing a trace of EDTA, was pturged with 99.99% nitrogen for 10 min ancl then illuminiatedl with a merctiry lamiip for 5 min in the apparatuis described previously (9) for preparationi of photobilirtibins. After illtumnination, the soluition was evaporated to dIryness in a streamii of nitrogeni at 40°C, and the residue used for studies. Photobilirubins IA, IB, and II, botlh '4C-labeled andl unlabeled, were isolated as described (9) by thin-layer chromatography of the prodtucts formed by anaerobic illumination of [14C]-or unlabeled bilirubin in chloroform or dimiiethyl stulfoxide soltution, uisig the 100-W mercury spot lamp. painted black and encased in altuminium foil to shield the emerging bile from light. The rats were then placed in Bollman-type restraining cages, and infused with 2.5% dextrose-0.45% NaCl (wt/vol) at 1.8 ml/h. For experiments to study the excretion of exogenous photobilirubins, the rats were maintained in darkness. To study the excretion of endogenously formed photoderivatives, the rats were placed under a phototherapy unit (6, 8) which contained six Daylite fluorescent lamps (General Electric Co., Cleveland, Ohio), that delivered 3.2 mW/cm2 of radiant flux at the skin suirface in the range of wavelengths from 400-500 nm.
Solutions of bile pigments for injectioni
To attain a stable minimum biliary excretion of bile salts and bilirubin, bile flow was diverted for 15-18 h before commencement of the experiments (6) . Bile, 1-2 ml/h, protected from light, was collected in iced tubes or directly into liquid nitrogen as re(quired. Collection tubes were changed every 1.5-2.0 h and kept on ice in the dark until analyzed on the same day. Serumi was obtained by centrifugation of clotted blood withdrawiv bv incisioni of the tail vein (lurinig bile collections, and by cardiac puncture at the conlclusioni of each experimenet.
Anialisis of seriim anid bile pigments
Total dliazo-reactive pigmenits were determined by the Michaelssoni method (19) taining 350 ,ug irradiated ['4C]bilirubin, and one control rat with a comparable solution of unirradiated [14C]bilirubin (5,500 dpm/,ug sp act for each). Thinlayer chromatography revealed that the irradiated bilirubin contained 81.7% bilirubin, 6.1% photobilirubins I, and 12.2% miscellaneous photoproducts. The injections raised the serum bilirubin levels by <23% above base-line values.
In the two test rats, 76 and 96% of the label injected as nonbilirubin photoproducts were recovered in the bile excreted during the next 5 h. Of this, 19 and 24% were converted to bilirubin, resulting in an increase in bilirubin outputs during only the 1st 2 h to 2.5 and 3.0 times the base-line excretion rates (Fig. 1 ). In the control rat, only 0.6% of the injected 14C was excreted, of which only 4% was bilirubin, and bilirubin excretion increased by only one-third. During the 1st 2 h after injection, the specific activity of the bilirubin in the bile of the two test animals was 14 and 17 times that of the control animal, with values 70 and 86% of the specific activity of the administered ['4C]bilirubins, but declined rapidly thereafter (Fig. 2) . Moreover, the specific activity of the initial bile bilirubin of the test animals was at least 10 times greater, whereas that of the control animal was less, than the specific activity of the corresponding serum bilirubin. Injection of unlabeled photobilirubins I (Fig. 3 ).
During the 1st h after intravenous administration to a single Gunn rat of 1 (6) . Injection of unlabeled photobilirubin I. Two Gunn rats each received a bolus of 180 ,ug photobilirubin II dissolved in 1.0 ml phosphate buffer. During the 1st 50 min after injection, output of diazoreactive material in bile increased to 2.6-2.8 times base-line values, but returned nearly to base line thereafter (Table II) . The azopigments formed with the postinjection bile sample exhibited the same atypical, orange-red color given by diazotization of photobilirubin II (9) . In both animals, inspection of the thinlayer chromatograph of the Folch extracts of the postinjection bile revealed a marked outpouring of a yellow, nonfluorescent pigment, C-9, that was not visible in the basal bile. Pigment C-9 corresponded in appearance and Rf value to the injected photobilirubin II, chromatographed concurrently, either after dissolution directly in chloroform, or after addition to basal bile followed by Folch extraction. The initial postinjection bile also exhibited moderate increments in pigments C-S (dihydroxybilirubin) and C-14 (the brownish, poorly soluble origin material), along with small increases in C-1 (bilirubin), the hydroxybilirubins (C-6, -7, and -13), and biliverdin (C-li). Of these products, traces of C-7 and C-li contaminated the administered photobilirubin II, whereas only bilirubin, C-5, -6, -7, and -14 were present in basal bile. A significant increase in C-14 occurred during dpm/,ug) 90.3% of the radioactivity was excreted in the bile of the Gunn rat in 3 h, almost all in the 1st h. On Folch extraction at pH 3.0, 12.1% of the radioactivity of the bile collected during the 1st h, remained in the upper, aqueous phase. Chromatography of the lower phase revealed a pattern similar to that seen with the unlabeled pigment, with half the excreted label recovered as unchanged photobilirubin II (C-9) and 6.5% as dihydroxybilirubin (C-5) . Small amounts of 14C appeared also in the other dihydroxyderivatives (C-6 and -7) and the immobile brown pigment at the origin (C-14). In contrast to the results after injection of photobilirubins IA or IB, <0.2% of the injected photobilirubin label was recovered as bilirubin. The remaining one-fourth of excreted radioactivity was scat- Infusion of unlabeled photobilirubin II (Table  IV) . A single Gunn rat, kept in the dark, was infused with photobilirubin II in buffer at a rate of 45 ug/h, approximately the normal rate of bilirubin production in the Gunn rat (22) . As revealed by visual comparison of the chromatograms, the bile collected before infusion contained no detectable C-9 and only traces of bilirubin. With infusion ofphotobilirubin II for 3 h, the output of diazo-reactive materials increased to twice the base-line rate, the C-9 bands became intensely yellow, and a slight increase in bilirubin was detected also. After 3 h, with the infusion of photobilirubin II continued, phototherapy was administered. During this period, excretion of C-9 appeared qualitatively undiminished, but there was a further increment in diazo-reactivity to approximately three times that of base line, largely due to a markedly enhanced output of bilirubin. After 4.75 h, with phototherapy continued, the photobilirubin infusion was halted; this resulted in a marked decrease in the excretion of C-9, while the output of bilirubin remained high. Throughout the study, less striking changes in the output of C-5 and C-14 paralleled those of C-9.
Identification of endogenously formed photobilirubins excreted in bile during phototherapy. Pooled bile, collected on ice and in the dark from two Gunn rats exposed to phototherapy for 9 h, was subjected to sequential Folch partition at pH 7 and 3, as described previously (2, 6). Chromatography of the lower phases confirmed prior reports (2, 6 ) that the pH 7 extract contained only bilirubin and porphyrins, whereas the pH 3 extract contained bilirubin and C-9 as the major components. The endogenous C-9 photopigment was eluted from the chromatogram and compared with authentic photobilirubin II, prepared in vitro by anaerobic illumination of bilirubin in dimethyl sulfoxide (9) . The two compounds, studied simultaneously, exhibited identical properties as follows: (a) visible absorption maxima at 441 nm in chloroform and 429 nm in methanol: (b) rapid and almost complete reversion to bilirubin on anaerobic illumination in chloroform; (c) reaction with diazotized sulfanilic acid in methanol to yield an atypical, orange-red azopigment; (d) stability in chloroform, methanol, dimethyl sulfoxide and 0.1 M NaOH, as long as light and oxygen were excluded; (e) formation of poorly soluble brown products (C-14) on exposure to acetic acid or Folch extraction at pH 3.0; (f ) formation of a plum-red color, but no biliverdin, on reaction with 2,3-dichloro-5,6-dicyano- * Photobilirubin II infused in phosphate buffer (see Table II ) at 45 gg/h. 4 As in Table II , diazo-reactive compounds expressed as A600nm/O.1 ml bile x ml/h; for bilirubin, A6o0nm x 9.61 = Mg bilirubin per 0.1 ml bile. § Semiquantitative assessment from visual intensity of band on thin layer chromatography plate.
p-benzoquinone in dimethyl sulfoxide (g) identical Rf values on thin-layer chromatography in three different solvent-gel systems (9) . Because the unstable photobilirubins I were not identified in the above study, we attempted to stabilize this pigment in bile by collecting the bile directly into liquid nitrogen in the dark, and extracting and chromatographing the bile pigments after only 2 h of bile collection. Phototherapy bile thus obtained contained abundant bilirubin and photobilirubin II, but also small amounts of a pigment, with the appropriate Rf value, that shared all the properties described previously (9) for photobilirubin 1. No such pigment was found in the bile of an unilluminated Gunn rat, collected and processed in identical fashion.
DISCUSSION
In 1971, McDonagh (1) produced evidence that photooxidation via autosensitized addition of singlet oxygen might constitute an important mechanism of bilirubin photodegradation. However, the major photoproducts predicted by this mechanism, 5,5'-diformyldipyrromethane and propentdyopents (23), were not found among the bilirubin derivatives excreted in Gunn rat bile during phototherapy (6), and the two major pigments excreted during phototherapy, bilirubin itself and a yellow, acid-labile, diazo-positive pigment called C-9 (6), were not reproducible by photo-oxidative singlet oxygen reactions. McDonagh (7) subsequently postulated that photoisomerization might produce tetrapyrroles that were sterically incapable of the internal hydrogen bonding of bilirubin IXa (18) , and thus would be sufficiently polar to be excreted in bile without conjugation.
Recently, Lightner et al. (13, 14) reported the formation of three photobilirubins during illumination of bilirubin in a variety of solvents under aerobic conditions, but were unable to purify these derivatives because of their thermal instability (16) . By illumination of bilirubin under anaerobic conditions that precluded oxidative reactions, we (9) and Onishi et al. (10, 11) produced and purified chromatographically a pair of unstable (I) and a pair of stable (II) photobilirubins. All the reported photobilirubins were more polar than the parent bilirubin IXa, being easily soluble in water and methanol. They also reverted to bilirubin IXa when reilluminated briefly with visible light, attaining a photoequilibrium in which < 10% of the pigment was in the form of the photobilirubins. Mass spectrometry (9, 24) and azopigment analysis (10, 11) indicated that these derivatives were neither photoadducts nor the IIIa, XIIIa, IX,3, IXy, or IX8 isomers of bilirubin.
Based on these properties, all three groups postulated that the photobilirubins resulted from configurational (geometric, Z to E) photoisomerization at the A4,5 and/ or A15,16 methene bridges of bilirubin IXa, which are normally in the Z configuration (18) . Unfortunately, these photobilirubins have not yet been prepared with sufficient quantity or stability to permit nuclear magnetic resonance spectroscopic analysis, which could provide rigorous proof of these tentative structural assignments.
All three groups have reported that the less polar photobilirubins (our IA and IB) are thermally unstable in the dark, reverting rapidly to bilirubin, especially in polar solvents (e.g., bile) (9) (10) (11) 14) . The reversion is retarded greatly by 1 mM EDTA, serum albumin, and nonpolar solvents such as chloroform (9) (10) (11) . These properties suggested that formation and excretion of these polar photobilirubins could explain the enhanced appearance of bilirubin IXa in bile during in vivo phototherapy (8) . Strong indirect evidence for this thesis has been the demonstration that the photobilirubins accumulate in the serum of Gunn rats (16) and human infants (11, 15) during phototherapy, and correlate temporally with the enhanced excretion of bilirubin IXa in their bile (15) . Moreover, when photobilirubinenriched serum from an illuminated donor Gunn rat was administered intravenously to another Gunn rat kept in the dark, large amounts of the natural bilirubin IXa,Z,Z isomer appeared in the bile of the recipient rat (16 (6) , injection of 14C-labeled photoproducts, isolated from Gunn rat bile during phototherapy, did not augment the excretion of bilirubin by recipient Gunn rats. This last observation is also against the possibility that endogenous bilirubin "piggy-backed" into bile in complexes with excreted photoproducts. Moreover, in the present stuidies, the similarity of the specific activity of the injected photobilirubins and the excreted bilirubin indicates that the latter is derived from the former, and not from the endogenous plasma bilirubin of vastly lower specific activity. The control experiment (Figs. 1 and 2) , in which only ['4C]bilirubin was injected and virtually no [14C]bilirubin was excreted, eliminates the contaminating bilirubin IXa as the source of the bilirubin found in bile during the injection of the photobilirubin I preparations. Of special importance was the demonstration, by appropriate precautions during collection and excretion of the bile, that photobilirubins IA and TB per se were excreted during phototherapy, but were not found in the bile from an unilluminated Gunn rat that was processed simultaneously. These observations support the proposal that these photobilirubins pass into bile before reversion to bilirubin IXa. The predicted in vivo stabilization of the photobilirubins IA and IB was evidenced also by the continued appearance of excess bilirubin in the bile for 2-3 h after the bolus injection of these photoisomers, and the recovery as ['4C ]bilirubin in the bile of two-thirds of the label administered as photobilirubin IA or IB per se. Thus, our experiments suggest strongly that photobilirubins IA and IB are the precursors of the bilirubin IXa that appears in bile during phototherapy, but it is appreciated that some means ofprolonged stabilization of the photobilirubins I in pure form is essential to achieve unequivocal documentation of both their in vivo behavior and their structural identification.
Much clearer was our demonstration that, after intravenous administration, the more stable photobilirubin II is excreted in the bile and corresponds to the other major photoproduct (C-9) that appears in the bile of the Gunn rat (6) and human infant (15) during phototherapy. It may correspond also to the "430 pigment" of Kapitulnik et al. (25) . Over half of injected [14C]-photobilirubin II was recovered as such in the bile, and virtually none reverted to bilirubin IXa,Z,Z in vivo. Photobilirubin II appeared to serve also as the in vivo precursor of the dihydroxylated bilirubins, C-5, -6 and -7 (2, 6), presumably via pathways not involving secondary photoreactions, since the recipient Gunn rats were maintained in the dark. Because only C-7 was in part produced from C-9 during extraction procedures, C-5 and C-6 are clearly natural derivatives resulting from biochemical reactions of photobilirubin II. By contrast, C-14, the insoluble brown pigment at the origin of the chromatogram (Table III) , is apparently in large part an artefact created by degradation of photobilirubin II during the Folch extraction at low pH. Since C-5 and C-6 are found in the bile of unilluminated Gunn rats, but increase during phototherapy, it is probable that photobilirubin II is more susceptible to hydroxylation than the parent bilirubin IXa,Z,Z. Alternatively, as suggested by McDonagh et al. (16) , small amounts of other conformers of bilirubin IXa,4Z,15Z may exist at equilibrium even in the dark, and serve as precursors for the dihydroxybilirubins found in Gunn rats not subjected to phototherapy.
Although each individual experiment was reported in only one or two animals, the major qualitative phenomena were observed in a larger number of animals, including those described here and other rats that received less satisfactory photobilirubin preparations during the developmental stages of this work. Thus, the appearance of bilirubin IXa in bile after administration of irradiated bilirubins or photobilirubins I is reported in five animals, and the excretion of intact photobilirubin II in four animals.
Considered together, all published studies suggest that the photobilirubins are geometric (Z,E) isomers of bilirubin IXa, whose formation may account for the major pathways of bilirubin photocatabolism in the Gunn rat and human neonate. These photoisomers presumably are formed rapidly when light penetrates to the bilirubin deposits in the skin and subcutaneous tissue, then partitioned to the plasma, taken up by the liver, and excreted into the bile. In bile, the thermally unstable photobilirubins IA and IB, believed to be the E,Z and Z,E isomers, rapidly revert to the Z,Z configuration, accounting for the augmented excretion of bilirubin during phototherapy of both Gunn rats (8) and human neonates (15, 26) . The more stable photobilirubin II remains mostly intact and constitutes the major polar photoproduct, but is in part hydroxylated at the methene bridges, by photo-independent reactions, to yield other minor derivatives. Together, these photoisomerizations and secondary reactions apparently account for >80% of the accelerated bilirubin catabolism during phototherapy (6, 15) .
